Profiling of human serum glycans associated with liver cancer and cirrhosis by IMS-MS - Wikidata - awgldk - TriplyDB

Profiling of human serum glycans associated with liver cancer and cirrhosis by IMS-MS

Profiling of human serum glycans associated with liver cancer and cirrhosis by IMS-MS

http://www.wikidata.org/entity/Q37055406

about

Serum glycoprotein-derived N- and O-linked glycans as cancer biomarkers A new ion mobility-linear ion trap instrument for complex mixture analysis Semi-automated identification of N-Glycopeptides by hydrophilic interaction chromatography, nano-reverse-phase LC-MS/MS, and glycan database search Shift reagents for multidimensional ion mobility spectrometry-mass spectrometry analysis of complex peptide mixtures: evaluation of 18-crown-6 ether complexes Diagnosis of liver cancer from blood sera using FTIR microspectroscopy: a preliminary study.Development of a nanoLC LTQ orbitrap mass spectrometric method for profiling glycans derived from plasma from healthy, benign tumor control, and epithelial ovarian cancer patients Characterizing ion mobility-mass spectrometry conformation space for the analysis of complex biological samples.The development of retrosynthetic glycan libraries to profile and classify the human serum N-linked glycome.Resolving structural isomers of monosaccharide methyl glycosides using drift tube and traveling wave ion mobility mass spectrometry Glycomic analysis of sialic acid linkages in glycans derived from blood serum glycoproteins.Structural resolution of carbohydrate positional and structural isomers based on gas-phase ion mobility-mass spectrometry.The effects of abundant plasma protein depletion on global glycan profiling using nanoLC FT-ICR mass spectrometry.High Performance IT-MS Sequencing of Glycans (Spatial Resolution of Ovalbumin Isomers).Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans: a potential methodology for cancer-biomarker discovery.An ion mobility/ion trap/photodissociation instrument for characterization of ion structure.Advances in analysis of human milk oligosaccharides.Quantification of fucosylated hemopexin and complement factor H in plasma of patients with liver disease Structural separations by ion mobility-MS for glycomics and glycoproteomics Glycomic profiling of tissue sections by LC-MS Comparative glycomic profiling of isotopically permethylated N-glycans by liquid chromatography/electrospray ionization mass spectrometry.Structural glycomic analyses at high sensitivity: a decade of progress Populations of metal-glycan structures influence MS fragmentation patterns.Ion mobility mass spectrometry analysis of isomeric disaccharide precursor, product and cluster ions.Mass spectrometry and glycomics One-Year Plasma N-linked Glycome Intra-individual and Inter-individual Variability in the Chicken Model of Spontaneous Ovarian Adenocarcinoma.Overtone mobility spectrometry: part 3. On the origin of peaks.Glycopeptide Site Heterogeneity and Structural Diversity Determined by Combined Lectin Affinity Chromatography/IMS/CID/MS Techniques.Quantitation of permethylated N-glycans through multiple-reaction monitoring (MRM) LC-MS/MS Comprehensive native glycan profiling with isomer separation and quantitation for the discovery of cancer biomarkers.Delineating diseases by IMS-MS profiling of serum N-linked glycans.Delineation of disease phenotypes associated with esophageal adenocarcinoma by MALDI-IMS-MS analysis of serum N-linked glycans.Mannose7 glycan isomer characterization by IMS-MS/MS analysis.Ion mobility-mass spectrometry analysis of serum N-linked glycans from esophageal adenocarcinoma phenotypes Analytical glycobiology at high sensitivity: current approaches and directions Travelling-wave ion mobility and negative ion fragmentation of high-mannose N-glycans.Carbohydrate structure characterization by tandem ion mobility mass spectrometry (IMMS)2.Identifying cancer biomarkers by mass spectrometry-based glycomics Defining putative glycan cancer biomarkers by MS.Glycomic Alterations in the Highly-abundant and Lesser-abundant Blood Serum Protein Fractions for Patients Diagnosed with Hepatocellular Carcinoma Ion Mobility-Mass Correlation Trend Line Separation of Glycoprotein Digests without Deglycosylation

P2860

Q28079101-7DC3C01C-7324-4D48-967D-D85C73BE314E Q28393063-CC5552D4-F27C-4BBD-9D90-3A222BEABB46 Q28731567-F41E0E84-55AB-4A2B-A615-3C3072BEF8EC Q28741976-2195BCC6-C0C3-41FA-9764-D16FDA80656D Q30360305-F4A65402-CA3C-4103-B588-ADE42F920C67 Q33396321-C149FAA6-AAED-45BE-8373-87AB30382FEB Q33413124-7D6B66D6-F223-46DE-8EE8-420EB4CF8ED5 Q33447457-F6DF18F0-96B4-4EA1-A4A0-362EB9CACA8C Q33453395-0A09C4A3-1FDF-4EF6-9248-587E3599C957 Q33546544-FF4DC519-CE9D-4734-AABD-3BECDFA347A7 Q33757508-9B776061-A4BF-44B2-B7FC-E778B64DA352 Q33836040-F43F9FBF-8703-4713-A524-6C77F46C64CB Q33936469-37B73393-F107-4D97-92B1-C58753EC134A Q34022368-BD57ED18-0B2C-4FB9-997B-A4FE7140FDEA Q34033237-F3849FCE-0DFA-4204-9FB7-A70199257B41 Q34268885-1F070267-1978-4DCA-9AD1-43D90E586FB2 Q34464343-B0B9AE82-0A01-444C-9A8B-A980F173C1DA Q34538635-EF3D21BA-6E70-4BDD-BC61-79E58AFEAB22 Q34601075-802F6716-C8FB-419C-B3A9-F69210B2D5CB Q34621113-30471297-0708-405D-B11E-12303EF11965 Q34656853-261F934D-E6EB-4DB2-8200-A6CF6DA833A2 Q34771619-28F13E9D-B3CC-43A5-A369-A5025DF36F48 Q35051146-8DF6158F-2DB4-469C-B547-E712804E2C09 Q35097817-0DDB1DAE-C637-4005-B238-3C21F2FB6C83 Q35161829-5B111E8D-51AD-40D1-9784-93AA4A86C9FA Q35660230-40C9A50D-4FAC-4823-A9B6-64F13EA67DA1 Q35763008-EEBB9DF4-CA4C-4C18-8FD2-2EC886A8B2EA Q35886419-7ADB5E10-8362-4BE2-8228-13CA8B4E5DCF Q35902976-09F28563-6087-486D-9266-A70553225D8B Q35913954-936C69D3-7C04-463D-A257-BDC20EF7D02C Q36331391-8319E0FE-7059-42DC-9ADE-48337F6020D7 Q36449040-5FF7747E-791F-457D-8792-71CEC2B72836 Q36501921-F463CCE5-26BD-4E59-A477-13DA9393C20C Q36651493-00954172-D9BB-42B6-B50E-278B8E4B206F Q36767085-51351BC1-25EF-43D4-AAD3-FD54288A6282 Q36787565-D19879E3-798F-4942-8FC5-01DBC31DF389 Q36904006-143E0C8C-2320-4EAA-9D7A-22E4A584760E Q36904030-6A59CA74-0593-496F-9BCF-5B42D4AE5B8E Q36936153-2F6E03DD-A7D5-4C99-85EB-ECD498C1B853 Q37057130-9549AD54-9236-4AEE-98FC-2918930ECC23

P2860

Profiling of human serum glycans associated with liver cancer and cirrhosis by IMS-MS

http://www.wikidata.org/entity/Q37055406

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Profiling of human serum glycans associated with liver cancer and cirrhosis by IMS-MS

@en

Profiling of human serum glycans associated with liver cancer and cirrhosis by IMS-MS.

@nl

type

label

Profiling of human serum glycans associated with liver cancer and cirrhosis by IMS-MS

@en

Profiling of human serum glycans associated with liver cancer and cirrhosis by IMS-MS.

@nl

prefLabel

Profiling of human serum glycans associated with liver cancer and cirrhosis by IMS-MS

@en

Profiling of human serum glycans associated with liver cancer and cirrhosis by IMS-MS.

@nl

P1433

Q37055406-5CE21CDE-1E95-4E7E-A946-3536745EA677

P1476

Q37055406-D9917030-74BD-46DA-89E7-70C09F72783C

P2093

Q37055406-0F240364-32FB-4E4F-B4AE-2BB155E6ADE0

Q37055406-121466F3-581C-4772-A7C7-9DE89FC1BD9E

Q37055406-5A45BBB2-DEFA-4DC1-B6B2-762AA862E7B2

Q37055406-608C2836-BB48-4EF4-860F-F93C4DC085C4

Q37055406-95051D6C-392C-449A-8646-F997744354E8

Q37055406-9B2BCBA2-F952-432A-A1CD-AF6E9F293F90

Q37055406-A8E96416-826F-4B5E-9494-562E877369E6

Q37055406-D8E97147-04D2-4F34-8CCE-09B21DBE90B6

P2860

Q37055406-00FCD88B-9AF0-4DC1-B20C-47C8BBEBCC8E

Q37055406-04B974C5-6A27-4766-8D0F-91A54124AF6E

Q37055406-058FB519-B3B5-4142-BA8D-94EED7893789

Q37055406-111C7CDA-86A0-4B6B-AEA0-6573FCE69DCD

Q37055406-34B4721A-407B-4C8C-8471-945B78DEF317

Q37055406-427118C3-254A-45FC-BEC6-5AC06CC211D2

Q37055406-42E87509-9A16-4778-B564-9DD93631AAA3

Q37055406-4A92902A-AF1C-4205-A41D-EDC6DE7C6EF3

Q37055406-5CF36CBF-075A-4DF4-B070-1E9E22551DC1

Q37055406-65306D76-EF9B-476E-B948-4AB17C9C70F9

P304

Q37055406-741FAF33-3DEA-4607-912F-FF8D0CCBF062

P31

Q37055406-D7921817-37BC-4061-AA0D-6F5D661142FF

P356

Q37055406-34547FB0-7FEF-4D0F-9D97-735E9ACB2CE9

P433

Q37055406-D6A9FCBD-6BF5-4A85-8E6C-81E09A1A8BA1

P478

Q37055406-A4A420BB-D6A4-4F2F-94A0-BBD87CFB86E8

P50

Q37055406-3CEC6B20-93F4-4D13-9D83-5C07931BBCB7

P577

Q37055406-B9C0FA63-6FA8-4B1E-AC11-948C5ABBC23B

P5875

Q37055406-15AC8E01-B013-458F-AFB8-18A94D4FDF70

P698

Q37055406-A5643DE2-D014-4BFF-8247-388E6BD0EC41

P921

Q37055406-CAA25717-3728-4699-AF63-D7A8786F7754

P932

Q37055406-C39639C4-44DF-49DE-A425-9D6DF82F332F

P356

P1433

Journal of Proteome Research

P1476

Profiling of human serum glycans associated with liver cancer and cirrhosis by IMS-MS

@en

P2093

D E Clemmer

http://www.w3.org/2001/XMLSchema#string

D Isailovic

http://www.w3.org/2001/XMLSchema#string

M D Plasencia

http://www.w3.org/2001/XMLSchema#string

M V Novotny

http://www.w3.org/2001/XMLSchema#string

R Goldman

http://www.w3.org/2001/XMLSchema#string

R T Kurulugama

http://www.w3.org/2001/XMLSchema#string

S T Stokes

http://www.w3.org/2001/XMLSchema#string

Z Kyselova

http://www.w3.org/2001/XMLSchema#string

P2860

Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry

Mass spectrometry-based proteomics

Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry

The human plasma proteome: history, character, and diagnostic prospects

Development of high throughput dispersive LC-ion mobility-TOFMS techniques for analysing the human plasma proteome.

Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour

Atmospheric pressure matrix-assisted laser desorption/ionization with analysis by ion mobility time-of-flight mass spectrometry.

Solid-phase permethylation of glycans for mass spectrometric analysis.

Mass spectrometry and protein analysis.

Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer.

P304

1109-1117

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/PR700702R

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5615137

http://www.w3.org/2001/XMLSchema#string

P698

18237112

http://www.w3.org/2001/XMLSchema#string

P921

liver cirrhosis

P932

3727278

http://www.w3.org/2001/XMLSchema#string